At least 15 Muscular Dystrophy Association research grantees, past and present, have won funding from the National Institutes of Health through the American Recovery and Revitalization Act (ARRA) to accelerate the search for treatments and cures for neuromuscular diseases.
Scentists at Oregon Health and Science University in Portland have developed an assisted-reproduction technique that has the potential to allow mothers with mitochondrial myopathies and other mitochondrial diseases to virtually eliminate the risk of passing on the disease to their children.
TUCSON, Ariz., April 28, 2006 — The Food and Drug Administration today announced approval of Myozyme, a new treatment for patients with Pompe disease, a rare genetic disorder also known as acid maltase enzyme deficiency.